• Poster

Cost-Utility Analysis for Pegaptanib in Age-Related Macular Degeneration in the UK: The Impact of Demographic and Disease Characteristics

Citation

Wolowacz, S. E., Roskell, N. S., Maciver, F., & Kelly, S. (2006, October). Cost-Utility Analysis for Pegaptanib in Age-Related Macular Degeneration in the UK: The Impact of Demographic and Disease Characteristics. Presented at ISPOR 9th Annual European Congress, .

Abstract